AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
Go back to AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention| AtriCure, Inc. (NASDAQ: ATRC) | Delayed: 52.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.59 | 52 Week High | $23.24 | |||
| Open | $52.59 | 52 Week Low | $13.44 | |||
| Day High | $52.59 | P/E | N/A | |||
| Day Low | $52.59 | EPS | $-0.45 | |||
| Volume | 216 | |||||
